1. Home
  2. BNC vs DCTH Comparison

BNC vs DCTH Comparison

Compare BNC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEA Industries Inc.

BNC

CEA Industries Inc.

N/A

Current Price

$7.02

Market Cap

286.8M

Sector

Industrials

ML Signal

N/A

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$10.44

Market Cap

289.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNC
DCTH
Founded
N/A
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.8M
289.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNC
DCTH
Price
$7.02
$10.44
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$22.60
AVG Volume (30 Days)
688.8K
739.3K
Earning Date
12-23-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$4,027,431.00
$79,603,000.00
Revenue This Year
N/A
$131.97
Revenue Next Year
N/A
$38.84
P/E Ratio
N/A
$300.67
Revenue Growth
27.46
251.54
52 Week Low
$4.65
$8.12
52 Week High
$82.88
$18.23

Technical Indicators

Market Signals
Indicator
BNC
DCTH
Relative Strength Index (RSI) 51.68 62.85
Support Level $6.65 $9.59
Resistance Level $7.72 $10.14
Average True Range (ATR) 0.59 0.44
MACD 0.22 0.16
Stochastic Oscillator 72.94 87.15

Price Performance

Historical Comparison
BNC
DCTH

About BNC CEA Industries Inc.

CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: